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Abstract 
Maintenance of plasma IgM levels is critical for immune system function and homeostasis in 
humans and mice. However, the mechanisms that control homeostasis of the activated IgM-
secreting B cells are unknown. After adoptive transfer into immune-deficient hosts, B-
lymphocytes expand poorly but fully reconstitute the pool of natural IgM-secreting cells and 
circulating IgM levels. By using sequential cell transfers and B cell populations from several 
mutant mice, we were able to identify novel mechanisms regulating the size of the IgM-
secreting B cell pool. Contrary to previous mechanisms described regulating homeostasis, 
which involve competition for the same niche by cells having overlapping survival 
requirements, homeostasis of the innate IgM-secreting B cell pool is also achieved when B 
cells populations are able to monitor the number of activated B cells by detecting their 
secreted products. Notably, B cell populations are able to assess the density of activated B 
cells by sensing their secreted IgG. This process involves the FcγRIIB, a low-affinity IgG 
receptor that is expressed on B cells and acts as a negative regulator of B cell activation, and 
its intracellular effector the inositol phosphatase SHIP. As a result of the engagement of this 
inhibitory pathway the number of activated IgM-secreting B cells is kept under control. We 
hypothesize that malfunction of this quorum-sensing mechanism may lead to uncontrolled B 
cell activation and autoimmunity. 
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Introduction 
Maintenance of plasma IgM levels is critical for innate and adaptive immune system function 
and homeostasis in humans and mice. Decreased IgM levels result in diminished innate 
protection against bacterial invasion (1, 2). In humans, splenectomy, a therapeutic measure 
following trauma, cancer or autoimmune diseases, results in increased susceptibility to 
bacterial infections (3); asplenic (Hox-11-/-) or splenectomized mice also show diminished 
immune responses to bacterial infection (2). Such reduction in the innate protection against 
bacterial invasion is related to decreases in both natural plasma IgM levels and the number of 
IgM-secreting cells (2). In contrast, increased IgM titers are often associated with 
autoimmunity (4, 5). For example, humans develop autoimmune disorders when they have 
primary immune deficiencies that are characterized by elevated natural IgM levels when B-
lymphocytes are unable to switch to IgG producing cells. These deficiencies could be due 
either to defective T-B cell cooperation, as is the case of CD40/CD40L deficiencies, or to an 
intrinsic inability of the B cells to perform class switch recombination (4, 5). Similarly, 
increased IgM levels in mice are associated with several autoimmune disorders (6). For 
example, mice with activation-induced cytidine deaminase (AID) defects that prevent class 
switch recombination develop hyper IgM-like syndromes that are associated with 
autoimmune diseases (7). Thus, any failure to maintain the homeostasis of IgM-secreting B 
cells is deleterious, either by increasing susceptibility to infection or by inducing autoimmune 
disorders; however, the underlying mechanisms are unknown. In most cases, homeostatic 
regulation is achieved by competition of different cells for the same “survival niches” (8, 9). 
However, it is unclear whether such mechanism would also apply to IgM homeostasis, as not 
only secreting B cell numbers should be maintained, but also the total amount of IgM they 
produce must also be regulated. It is also not clear, which mechanisms could limit lymphocyte 
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numbers during immune responses, in situations where resources are not limiting and 
physiological niches may be disrupted. 
In here we report an experimental strategy allowing studying the mechanisms involved in this 
regulation. Indeed, in contrast to T lymphocytes that undergo considerable homeostatic 
expansion when transferred into immune-deficient (10) naïve B lymphocytes expand poorly 
but reach a stable equilibrium and fully reconstitute the pool of IgM-secreting B cells and 
circulating IgM levels (11). The size and composition of this pool is tightly controlled as it 
remains stable for up to 6 months after transfer, independently of the number of injected naïve 
B cells (11). Thus, in these host mice the number of Ig-secreting cells is kept under strict 
homeostatic regulation as observed in intact mice (8). This model is therefore ideal to study 
the mechanisms of homeostasis of the number of IgM-secreting B cells, since only an 
adoptive transfer strategy allows the follow-up of different B cell populations (recognized by 
different allotypes) in the same mouse. Indeed, by using sequential transfers of B cell 
populations from several mutant mice, we identified feedback mechanisms regulating the size 
of the IgM-secreting B cell pool in a B-cell specific manner, i.e. excluding side effects 
induced by the mutations in other non-lymphoid cells. We found that contrary to the previous 
mechanisms described regulating homeostasis, which involve competition for the same niche 
by cells sharing overlapping survival signals (8, 9), homeostasis of the innate IgM-secreting B 
cell pool is also achieved when B cell populations are able to monitor the number of activated 
B cells by detecting their secreted products. Notably, B cell populations are able to assess 
their density and limit the number of activated IgM-secreting B cells when they sense the 
levels of secreted IgG via FcγRIIB, a low affinity IgG receptor that is expressed on B cells 
and acts as a negative regulator of B cell activation (12) by a SH2-containing inositol-5-
phosphatase 1 (SHIP1)-mediated pathway (12, 13). These results reveal a new mechanism of 
homeostatic regulation, which recalls mechanisms found in procariots, which have been 
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collectively named as quorum sensing (14, 15). Importantly, it finally explains the 
development of autoimmune conditions when IgG production is impaired, and the apparent 
paradox of the beneficial effects of IV Ig therapy in several autoimmune disorders (16).  
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Materials and Methods: 
Mice and cell transfers. C57BL/6(B6).Ly5bIgHb, B6.Ly5aIgHb, B6.Ly5bIgHa, B6.Ly5aIgHa, 
B6.Ly5bIgHaIgMs-/- (17), B6.Ly5bIgHbCD3ε-/-, B6.Ly5aIgHaCD3ε-/-, B6.Ly5bIgHbFcγRIIB-/- 
(12), B6.Ly5aIgHbSHIP1-/- (18), and B6.Rag2-/- mice were purchased from Charles River, 
France, ;  the Centre Des Techniques Avancées (CDTA), Centre Nationale de la Recherche 
Scientifique (CNRS), Orleans, France, ; or Taconic, Hudson, NY, USA; or were from our 
animal facilities at the Institut Pasteur. LN cells containing approximately 5x106 B cells were 
injected i.v. into Rag-/- hosts. In experiments involving sequential cell transfers the injected 
populations differed by allotype markers (Ly5a or b
 
and IgHa or b allotype). Recipient mice were 
bled and killed at different times after cell transfer. The number of B cells derived from each 
cell population was calculated. Experiments were preformed according to the Pasteur Institute 
Safety Committee in accordance with French and European guidelines and the ethics 
Committee of Paris 1 (permits 2010-0002, -0003 and -0004). 
Flow Cytometry and cell sorting. Cells were stained using anti-CD19 (1D3), anti-IgMa 
(DS1), anti-IgMb (AF6-78), anti anti-Ly5a (A20), anti-Ly5b (104), anti-CD21 (7G6), anti-
CD23 (B3B4), anti-IgM (R6-60.2), and anti-IgD (11-26c.2a) monoclonal antibodies from BD 
Pharmingen coupled with the appropriate fluorochromes. Four/six color staining used the 
appropriate combinations of FITC, PE, TRI-color, PerCP, PECy7, biotin, APC, 
AlexaFluor647 and APCCy7-coupled antibodies. Biotin-coupled antibodies were secondarily 
labeled with APC-, TRI-Color- (Caltag, San Francisco, CA, USA), PerCP- (Becton 
Dickinson, San Jose, CA, USA) or APCCy7-coupled (Pharmingen) streptavidin. Dead cells 
were excluded based on light scattering. All acquisitions and data analysis were performed 
with a FACSCanto or LSRFortessa (Becton Dickinson, San Jose, CA, USA) interfaced to 
with the Macintosh FlowJo software. Subsets of follicular (CD21highCD23high), marginal 
(CD21highCD23low) or activated (CD21lowCD23low) B cells were sorted on a FACSAria 
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(Becton Dickinson, San Jose, CA, USA) cytometer. The purity of the sorted populations 
varied from 90-95%.  
ELISA and ELISA Spot Essay. Sera Ig concentrations were quantified by ELISA. Plates 
were coated either with antibodies to total IgM, IgMa or IgMb and saturated with PBS-1% 
gelatin. Dilutions of sera were added. After incubation (1 hour, 37°C) and washing, PO-
labeled goat anti-mouse IgM antibodies were added. After incubation and washing, bound 
antibodies were revealed with the substrate O-phenylenediamine and H2O2. The reaction was 
stopped after 10 min. by addition of 10% SDS and the absorbance read at 450nm in a titertek 
multiscan spectrometer (Flow laboratories, Irvine, Scotland). Titration of serum IgM and IgG 
was performed using purified mouse IgM or IgG as standards purified mouse IgM or IgG 
(Southern Biotechnology, Inc.). Ig concentrations were determined by comparing the 
displacement of the dilution curves in the linear interval between standards at a concentration 
of 10 mg/ml and the serum samples. Specificity of the reactions for the detection of both IgMa 
and IgMb was confirmed using serum from B6.IgHa and B6.IgHb donor mice. For 
autoantibodies, plates were coated with mice mouse tubulin or DNA. To test for OxLDL, we 
used the OxLDL-Ab ELISA kit purchased from IMTEC. The quantification of IgM secreting 
cells was assayed by ELISA Spot Essay technique. Briefly, plates were coated with goat anti-
mouse IgM antibodies or anti-allotypic IgM antibodies. After saturating, the cells were 
distributed into the micro wells in RPMI1640-2%FCS. The plates were incubated for 4-6 h at 
37°C, 5% CO2 atmosphere. After extensive wash, plates were incubated with goat anti-mouse 
IgM labeled with alkaline phosphatase. After washing, the revealing substrate was added 
(2,3mM 5-bromo-4-chloro-3-indolyl phosphate diluted in 2-amino-2-methyl-1-proprenolol 
buffer). 
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Results  
 
Replenishment of the IgM-secreting B cell pool is strictly controlled. Upon adoptive 
transfer of LN cells from immune competent into immune deficient mice, T cells expanded to 
reconstitute a considerable fraction of the peripheral T cell pool (10). In contrast, the majority 
of the IgMlowIgDhighCD21int/highCD23high follicular LN B cells (Fig. 1a) did not proliferate and 
therefore, the number of recovered B cells was limited and did not exceed 2 × 106 cells (11), 
i.e. less than the number of injected cells. The size and composition of the pool of persisting 
cells was regulated independently of the number of injected B cells and remained stable for up 
to 6 months after transfer (11). Most of the persisting B cells expressed activated 
IgMhighIgDlowCD21highCD23low marginal zone (MZ) or IgMlowIgDlowCD21lowCD23low 
phenotypes (Fig. 1a). In the spleen, Ig-secreting cells were recovered with increased 
frequency, primarily among the CD21lowCD23low B cells (Fig. 1b). However, since 
quantification of the total number of activated B cells in the spleen is not a reliable method to 
evaluate the total size of the activated B cell pool, as activated B cells could have migrated to 
organs (as the liver, gut or the flat bones bone-marrow) where numbers cannot be accurately 
measured, we chose the serum IgM levels as the most reliable indicator of the state of B cell 
activation and of the total number of IgM-secreting B cells in the whole mouse 
(Supplementary Note 1). In these host mice we found that the serum IgM and IgG 
concentrations were similar to those of control mice, despite reduced B cell numbers (Fig. 1c). 
Interestingly, the titers of self-reactive antibodies were increased compared to donor mice 
(Fig. 1d), suggesting that the persisting B cell populations were naturally selected on the basis 
of their reactivity against self and environmental antigens. These findings indicate that the 
transfer of mature B cells restored a stable and tightly controlled pool of IgM-secreting B cells 
in immune-deficient mice, but they do not provide insight into the homeostatic mechanisms 
that limits their number.  
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Feedback mechanisms control newly arriving B cell activation and IgM 
production. To identify the mechanisms that control the number of the IgM-secreting cells, 
we investigated whether an established population of B cells could modify the fate of a newly 
transferred B cell population. To do this, we used a sequential cell transfer strategy as follows. 
Rag-deficient murine hosts were first injected with LN cells from Ly5aIgHa donors; second, 4 
weeks later, the hosts were injected with LN cells from double congenic Ly5bIgHb mice 
(Supplementary Fig. 1). We evaluated the number, phenotype, and function of the B cells 
recovered 6 weeks after the transfer of the second population into the hosts. We found that, 
amongst the second population, the number of naïve B cells recovered was not significantly 
altered by the presence of a first B cell population. However, the fraction and number of 
activated B cells (CD21highCD23low and CD21lowCD23low) was significantly reduced in hosts 
injected first with B cells from Ly5aIgHa donors compared to controls (Fig. 2a). 
Consequently, the amount of IgMb that the second B cell population generated in the Rag-
deficient hosts was significantly lower than the amount generated by the same cell population 
when transferred alone into naïve hosts (Fig. 2b). At the same time, total IgM levels were 
slightly greater in mice receiving both B cell populations (Fig. 2b). In summary, we found 
that in mice injected sequentially with two LN cell populations, B cells from the first 
population replenished the compartment of activated IgM-secreting cells leading to normal 
serum Ig levels and used a “feedback” mechanism to regulate activation of the second 
population of transferred B cells and, ultimately, their IgM production. Thus, by using this 
sequential cell transfer strategy we unraveled feedback mechanisms that maintained the 
number of the activated IgM-secreting B cells stable. This feedback regulation could result 
from competition for cellular niches (8, 9), but could also occur in response to soluble factors 
secreted by the first B cell population. 
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Plasma IgG regulates the number of activated B cell and IgM production. To 
investigate whether secreted specific B cell products, such as immunoglobulin, were involved 
in the feedback regulation mechanism, we investigated the role of IgM produced by the first B 
cell population. Rag-deficient mice were injected with a population of Ly5bIgHa LN cells 
from IgMs-/- mice; the B cells of these donor mice express but cannot secrete IgM (17). Four 
weeks later, mice were injected with LN cells from wild-type (WT) Ly5aIgHb mice. As a 
control, the second WT cell population was also transferred into hosts that were not injected 
with the first cell population. The two groups of mice were sacrificed 6 weeks after transfer of 
the WT cell population. As shown in Fig. 3a the amount of IgMb produced by the WT B cell 
population were markedly lower in mice already hosting cells from IgMs-/- donors than in host 
mice that received only the WT population (Fig. 3a). We concluded that IgM produced by the 
first population of B cells was not responsible for the feedback effect, since secretion of IgM 
was disabled in those cells.  
Since B cells from IgMs-/- donors can secrete IgG (17) (Supplementary Figure 2), we 
next investigated the role of IgG in feedback inhibition. B cell class-switch recombination and 
IgG production requires T cell help and consequently T cell deficient mice show severely 
reduced levels of serum IgG (19). Therefore, to prevent strong IgG production by the first 
population of transferred B cells, Rag-deficient mice were injected with LN cells from 
Ly5bIgHa CD3ε-/- T cell deficient mice (Supplementary Note 2) and, 4 weeks later, with LN 
cells from Ly5aIgHb WT donors. Of note, B cells from CD3ε-/- mice behave similarly as B 
cells from WT donors in that the number of recovered cells was identical. We monitored the 
number of activated B cells and the IgMb produced by the second WT B cell population 6 
weeks after the second cell transfer. In the quasi absence of IgG secreted by the first 
population of B cells (Supplementary Figure 2), there was no inhibition of IgM production by 
the second B cell population (Fig. 3b).  
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We had observed that the level of feedback inhibition of the IgM production by the 
second B cell population was variable in different host mice injected with two WT 
populations. Considering that the feedback inhibition seems to be determined by the presence 
of IgG, we compared the IgM levels produced by the second B cell populations with the IgG 
levels present in individual mice from several different experiments. Notably, we found that 
the amount of IgM produced by the second B cell population inversely correlated with IgG 
levels in the host serum (Fig. 3c).  
To confirm the role of IgG in the feedback regulation of IgM production, we transferred 
LN cells into Rag2-deficient hosts that were either untreated (control) or injected with 
purified mouse IgG. The number of B cells with an activated phenotype and the IgM 
production were significantly reduced in the mice injected weekly with an IgG dose required 
to reach and maintain the physiological levels of serum IgG (Fig. 3d), but not in mice injected 
with lower doses of IgG or in mice receiving as control soluble IgMs (Supplementary Note 3 
and Supplementary Figure 3). These findings also indicate that the IgG-mediated inhibitory 
signals require threshold levels of circulating IgGs. If these levels are not attained, as it was 
the case in mice receiving lower doses of IgG or injected with B cells from CD3-/- origin, B 
cell activation and IgM production are not inhibited.  
In conclusion, our findings, clearly demonstrate that an active IgG-dependent 
suppressive mechanism can regulate IgM production. In the absence of IgG secretion by the 
first B cell population, IgM production by the second B cell population was not inhibited, and 
the amount of IgM produced by the second B cell population was inversely correlated with 
the IgG level in the host serum. More importantly, they indicate a presence of a yet non-
described mechanism of homeostatic control. It has been proposed that homeostasis of Ig-
secreting cells is due to competition for a common niche of restricted size (8, 9). We now 
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show that, in the absence of competing populations, passively administered IgG reduced 
activation and further IgM production by subsequently introduced B cells.  
The inhibitory FcγRIIB is required for IgG-mediated feedback regulation. To 
investigate the mechanism of action underlying the IgG-dependent control of IgM production, 
we first injected Rag-deficient mice with LN cells from Ly5aIgHa WT mice; 4 weeks later, we 
injected them with a second population of LN cells from either WT or FcγRIIB-/- Ly5bIgHb 
donors. FcγRIIB is a low-affinity IgG receptor expressed on B cells that acts as a negative 
regulator of B cell activation (12). We found that the first (WT) B cell population did not 
suppress the second B cell population that lacked FcγRIIB (Fig. 4a, b), but was able to 
suppress 50% of the IgM production by a population of WT B cells (Fig. 4b). Inhibition of B 
cell activation may require FcγRIIB cross-linking, which can be achieved in the presence of 
either immune complexes or Ig aggregates (20). Notably, as mentioned we found higher titers 
of self-reactive antibodies in the sera of cell transfer host mice than in donor mice (Fig. 1d). 
These autoantibodies might form immune complexes that could either cross-link FcγRIIB or 
co-aggregate B cell receptors (BCR) with FcγRIIB and generate negative signals (20) by 
enabling tyrosyl-phosphorylation of FcγRIIB and recruitment of SHIP (13). To test this 
hypothesis, we injected Rag-deficient mice first with Ly5bIgHa WT cells and then, 4 weeks 
later, with a population of cells from either WT or SHIP1-/- Ly5aIgHb donors (18). We found 
that WT B cells, while inhibiting a second population of WT B cells, failed to reduce the 
number of activated SHIP1-/- Ly5a B cells or their IgMb production (Fig. 4c, 4d). Since these 
findings were obtained upon adoptive cell transfer into lymphocpenic hosts their validity 
could be questioned, as the new environment would not reflect that of an intact mouse. 
Nevertheless, the size and composition of the IgM-secreting B cell pool remains stable for up 
to 6 months after transfer indicating that its homeostasis mimics the rules observed in intact 
mice. By using the strategy of sequential transfer of B cell populations from several mutant 
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mice, we were able to study the mechanisms regulating the size of a stable IgM-secreting B 
cell pool. Notably, our findings obtained using adoptive cell transfers, were fully supported by 
the observation that both intact non-manipulated FcγRIIB-/- and SHIP1-/- mice had IgM serum 
levels that were significantly higher than those of control littermates (Fig. 4e). Additionally, 
the cell transfer strategy demonstrated that these defects are B-cell specific and not induced 
by the lack of expression of the FcRIIB or SHIP1 on other non-lymphoid host cells. Taken 
together, these results show that there are feedback mechanisms that regulate the number of 
activated B cell and plasma IgM levels and that these mechanisms involve plasma IgG- and 
FcγRIIB-mediated, SHIP1-dependent negative signals (Supplementary Note 4 and 
Supplementary Fig. 4).  
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Discussion 
The strategies to approach autoimmune disorders displaying elevated immunoglobulin 
(Ig) levels in the absence of obvious immunization are yet unclear. These disorders include 
hyper IgM syndromes and other pathological conditions such as SLE. In some cases, 
therapeutic intervention with the administration of IV Igs were shown to have beneficial 
effects (16) but it appears paradoxical that in steady-state conditions where Ig levels are 
already increased and induce pathology, further increases in circulating Ig could still have any 
beneficial effects. Above and beyond the possible anti-inflammatory effects of the 
administered Igs (21), the present findings showing that there are feedback mechanisms that 
regulate the number of activated B cell and plasma IgM levels and that these mechanisms 
involve plasma IgG- and FcγRIIB-mediated, SHIP1-dependent negative signals, may provide 
another explanation to this phenomenon.  
It has been long known that passively administered antigen-specific IgG can suppress or 
enhance specific primary thymus-dependent (22, 23) and thymus-independent IgM antibody 
responses (24). It is generally accepted that IgG-mediated suppression is antigen-specific (22). 
The suppressive effects could either be due to epitope masking and antigen sequestration by 
the high affinity IgG preventing initiation of new IgM responses (23), or be mediated by an 
Fcγ-dependent regulation of B cell activation (for review see (22)). Trials on whether F(ab’)2 
fragments kept the suppressive activity of intact IgG have given contradictory results (25). It 
has also been reported that IgG suppressed specific antibody responses as efficiently in FcγR-
deficient mice as in wild type controls (26, 27) questioning the role of this inhibitory receptor 
in the control of immune responses. However, FcγRIIB-deficient mice down regulate late 
responses to immune complexes (28) or during inflammation (29, 30) suggesting that these 
receptors may act to prevent overextended immune responses (25). It should be pointed out 
that studies that investigated the in vivo role of IgG-mediated regulation of B cell activation 
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and immune responses have all used actively immunized mice, under conditions where high 
titers of antigen-specific antibodies were produced (22, 25). The novelty of our approach 
resides on the fact that we preformed our studies in the absence of any antigenic challenge. In 
these novel conditions our results show that circulating IgG, constitutively present in non-
immunized mice, may have a fundamental role in controlling natural activated B cell numbers 
and the IgM they produce. They seal a hiatus and provide new valuable information as they 
demonstrate that FcγRIIB-dependent negative regulation controls B cell activation without 
any intentional immunization.  
We show that regulation of IgM production engages a FcγRIIB-mediated, SHIP1-
dependent inhibitory feedback loop in which B cells themselves sense the number of activated 
B cells by detecting their secreted IgG. When there are enough activated B cells, the high 
titers of IgG and self-reactive antibodies that they produce can lead either to FcγRIIB-
mediated aggregation by immune complexes, possibly inducing activated B cell apoptosis 
(31, 32) or to co-aggregation of BCR and FcγRIIB, which dampens B cell activation (20). 
Either mechanism may prevent the accumulation of activated IgM-secreting B cells. 
However, while direct FcγRIIB cross-linking may inhibit B cells independently of their 
antigenic-specificity and affect a large fraction of the cells, BCR and FcγRIIB co-aggregation 
will preferentially inhibit self-reactive B cells. Considering the stronger effects observed 
using SHIP1-deficient B cells, it is possible that alternative FcγRIIB-independent inhibitory 
pathways may also participate in the control of the IgM-secreting cell pool. SHIP was indeed 
shown to control activation/proliferation signals triggered by a variety of receptors that 
activate PI3 Kinase (13). Once IgG levels reestablished normal B cell activation can proceed 
in response to new antigenic stimulation. 
Our current findings may provide an evolutionary explanation for the expression of 
inhibitory Fcγ receptors by B cells: By simultaneously allowing detection of plasma IgG 
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levels and inhibiting B cell activation, these receptors contribute to control the number of 
activated Ig-secreting B cells and prevent autoimmune disorders. They indicate that self-
reactive B cells can expand and secrete auto-reactive Igs if not held in check by sufficient IgG 
in their environment. This notion is supported by other independent data. The inability of B 
cells to detect plasma IgG because of defects in FcγRIIB expression or signaling leads to 
increased IgM levels and autoimmune disease (12, 29, 33-35). Altered human FcγRIIB 
signaling in B cells resulting from the I232T polymorphism (36, 37) as well as decreased 
FcγRIIB expression in memory B cells (38) have been reported in SLE patients. Inversely, 
partial restoration of FcγRIIB expression in the B cells of FcγRIIB-/- mice (39) or FcγRIIB 
overexpression in B cells reduces systemic lupus erythematous (SLE) incidence (40). Finally, 
the failure to produce IgG either because of early thymectomy in toads (41), inappropriate T-
B cell cooperation humans (5) (Supplementary Note 5) or because of the intrinsic inability of 
AID-mutant B cells to switch to IgG production in both mice and human (4, 7) results in 
hyper-IgM syndromes and autoimmune pathology. They may also be of relevance to the 
perception of the proposed “hygiene hypothesis” (42). Indeed, increase incidence of infections 
in the developing countries may lead to higher serum titers of IgG and thus, help to prevent 
development of autoimmune and allergic diseases.  
Our findings also suggest an as-yet unsuspected physiological role for natural self-
reactive antibodies. Specifically, it has never been clear why natural self-reactive Abs should 
be allowed to exist; but our observation of IgG-mediated feedback regulation of innate IgM in 
normal non-immunized mice suggests that natural self-reactive antibodies, which make up a 
significant fraction of the natural plasma Ig (43), by facilitating FcγRIIB aggregation provide 
a “warning signal” that reflects B cell density. Thus, natural self-reactive Abs might 
participate in activated B cell homeostasis under physiological steady-state conditions.  
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In conclusion, these results identify a new mechanism of homeostatic control. So far, in 
mammals, homeostatic control was believed to be due to competition of cellular populations 
for a common niche of restricted size, defined by the ensemble of cellular interactions and 
trophic factors required for cell survival (8, 44). However, in situations where resources are 
not limiting, i.e. immune responses, excess of self-antigens or cytokines, it is not clear, which 
mechanisms could limit expanding lymphocyte numbers. Thus, the question: how lymphocyte 
populations “count” the number of their individuals and how do they “know” when to stop 
growing? We now show that in absence of competing cell populations, passively administered 
IgG reduced activation and IgM production by subsequently introduced B cells. Thus, we 
propose that control of lymphocyte numbers could also be achieved by the ability of 
lymphocytes to perceive the density of their own populations (44). Such mechanism would be 
reminiscent of the primordial “quorum-sensing” systems used by some bacteria in which a 
bacterium senses the accumulation of bacterial signaling metabolites secreted (by the same or 
other cells), allowing the bacterium to sense the number of cells present in a population and 
adapt their growth accordingly (14, 15). In summary, these “quorum-sensing” mechanisms 
allow bacteria to coordinate their gene expression according to the density of their population 
(14, 15). Quorum sensing can play a critical role in lymphocyte homeostasis with the proviso 
that lymphocytes have the capacity to assess the number of molecules they interact with and 
can mount a standard response once a threshold number of molecules is detected. The 
situation described here seems to support this hypothesis. We found that homeostasis of the 
innate IgM-secreting B cell pool is achieved when total B cell populations are able to monitor 
the number of activated B cells by detecting products secreted by some of their members (Fig. 
5a). The ability of B cells to detect plasma IgG levels through such a “quorum-sensing” 
mechanism may be crucial to immune system homeostasis, providing a critical checkpoint 
mechanism to prevent excessive B cell activation and autoimmunity. Malfunction of this 
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“quorum-sensing” mechanism may lead to uncontrolled B cell activation and autoimmune 
disease (Fig. 5b, c). It is possible that similar quorum-sensing mechanisms may work to 
maintain the homeostasis of other lymphocyte populations (44) or control organ size during 
development. 
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Figure Legends: 
Figure 1 – Fate of LN B cells transferred into Rag-deficient hosts. a., LN cells containing 
about 5x106 B cells were transferred i.v. into immune deficient hosts. Left dot plots show the 
IgM, IgD (top), and CD21, CD23 (bottom) phenotype of donor LN B cells before transfer 
(gated on CD19+ cells). Right dot plots show the IgM, IgD (top), and CD21, CD23 (bottom) 
phenotype of the donor B cells recovered from the spleen of the host mice 8 weeks after 
transfer. The relative representation of the different CD21, CD23 subpopulations is displayed. 
Note that the majority of the B cells recovered 8 weeks after transfer into Rag-deficient hosts 
showed IgMhighIgDlow or IgMlowIgDlow and CD21highCD23low or CD21lowCD23low activated 
phenotypes. b., Different populations of B cells follicular (FO - CD21int/highCD23high), 
marginal zone (MZ - CD21highCD23low), and CD21lowCD23low B cells recovered from the 
spleen of  host mice 8 weeks after B cell transfer were purified by cell sorting and the number 
of IgM-secreting cells in each B cell subset detected by ELISPOT. Bars show the mean % of 
IgM-secreting cells among donor B6 spleen B cells and total host spleen B cells as well of the  
sorted follicular (FO - CD21int/highCD23high), marginal zone (MZ - CD21highCD23low), and 
CD21lowCD23low B cells recovered from the spleen of  host mice 8 weeks after B cell transfer. 
Note that the majority of IgM-secreting cells detected by ELISPOT were recovered among the 
activated CD21lowCD23low B cells. Each column represents the mean of values for 3 
individual mice. Similar findings were obtained in 3 independent experiments. c., Shows the 
IgM (left) and IgG (right) concentrations in the serum of donor B6 mice and of Rag-/- hosts 8 
weeks after B cell transfer. Each bar represents the mean ± sd of values for 8 individual mice. 
Note that in spite of the low number of B cells recovered, Ig concentrations in these hosts 
were identical or slightly higher than those present in the donor mice. Similar results were 
obtained in more than 7 independent experiments. d., Titers (expressed in arbitrary units) of 
self-reactive anti-mouse DNA (left), anti-mouse tubulin (middle), and anti-mouse OxLDL in 
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the serum of individual donor B6 mice or in the serum of Rag-deficient hosts. The hosts were 
injected 8 weeks previously with LN B cells from WT B6 mice. Bars indicate the mean 
values. Note the increased titers of self-reactive antibodies in the serum of the host mice. 
Statistically significant differences are indicated (* p < 0.05; *** p < 0.001). 
Figure 2 – Sequential B cell transfers. a., Shows the number of FO - CD21int/highCD23high  
(left panel), MZ - CD21highCD23low (middle panel), and CD21lowCD23low (right panel) 
recovered from the second Ly5bIgHb population when injected alone (left) or into mice 
injected 4 weeks before with a first Ly5a IgHa cell population. Each bar represents the mean ± 
sd of values for 9 individual mice. Note that while the number of resting B cells was not 
altered, the number of activated CD21highCD23low and CD21lowCD23low present among the 
second set of B cells was significantly lower when these cells are were transferred into host 
mice homing already injected with a first set of B cells. b., Shows the quantity of IgMb 
produced by the second B cell population when transferred into naïve hosts (left) or into a 
host containing a first B cell population. Each bar represents the mean ± sd of values for 9 
individual mice. Note the significantly reduced IgM production by the second B cell 
population when these cells were transferred into mice containing a first set of B cells 
transferred 4 weeks before (right). Note that the total IgM concentrations were slightly greater 
in mice injected with two B cell populations than in the mice injected with the first population 
only (left). Similar results were obtained in five independent experiments or when the order of 
injection of the two B cell populations was inverted. Statistically significant differences are 
shown (* p < 0.05; *** p < 0.001). 
Figure 3 – Role of immunoglobulin in feedback regulation of IgM production. a, The 
IgMb produced by a second Ly5aIgHb B cell population transferred alone into naïve mice or 
into mice pre-injected 4 weeks before with a first population of cells from Ly5bIgHa µs-/- 
donor mice. Each bar represents the mean ± sd of values for 6 mice. Note that in spite of the 
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inability of the first B cell population to secrete IgM, the IgM production by the second 
population was significantly reduced in these hosts as compared to its production in naïve 
hosts. Similar results were obtained in a second independent experiment.  b, The IgMb 
produced by a second Ly5aIgHb B cell population from normal donors transferred alone into 
naïve mice or into mice pre-injected 4 weeks before with a first population from Ly5bIgHa 
CD3ε-/- donors. Each bar represents the mean ± SD of values for 6-9 mice. Note that in this 
case, the levels of IgM produced by the second B cell population were identical in the two 
groups of host mice (p = NS). Similar results were obtained in a second independent 
experiment.  c, Correlation of the levels of IgM produced by the second population with IgG 
levels present in the sera of 24 host mice pooled from different experiments. The correlation 
coefficient is shown (r2 = 0.47, p < 0.001). d, The IgM produced by the B cells of a LN 
population transferred alone into untreated naïve mice or into mice injected i.v. with 1mg of 
purified soluble mouse IgG (Innovative Research, Inc.) the day before cell transfer and 
thereafter intraperitoneally every week for 5 weeks. Each bar represents the mean ± SD of 
values for 10 mice. Note that in mice injected with IgG, the IgM production by the transferred 
B cells was significantly reduced. Similar results were obtained in a second independent 
experiment. Statistically significant differences are shown (** p < 0.01; *** p < 0.001). 
Figure 4 – Role of the FcRγIIB and SHIP1 in feedback regulation of IgM production. a, 
The number of MZ - CD21highCD23low (left panel) and CD21lowCD23low (right panel) B cells 
recovered from the second FcRγIIB-/- Ly5bIgHb cell population when injected alone or into 
mice injected 4 weeks before with a first Ly5aIgHa WT population. Each bar represents the 
mean ± SD of values for 12-14 mice. Note that the number of activated CD21highCD23low and 
CD21lowCD23low present among the second set of B cells was not modified by the presence of 
a first set of B cells. b, The IgMb titers produced by a second population of WT (left) or 
FcRγIIB-deficient (right) B cells transferred into Rag-deficient mice injected 4 weeks before 
 28 
with cells from WT IgHa donors expressed as a % of the control levels obtained after their 
transfer into naïve Rag-deficient hosts. Note that the IgMb production by FcRγIIB-deficient B 
cells was not inhibited in the presence of a first population of WT B cells. Each bar represents 
the mean ± SD of values for 12-14 mice. Data shown were pooled from two independent 
experiments. c, The number of MZ - CD21highCD23low (left panel) and CD21lowCD23low (right 
panel) B cells recovered from the second SHIP1-/- Ly5aIgHb population when injected alone 
(left) or into mice injected 4 weeks before with a first Ly5bIgHa population. Each bar 
represents the mean ± SD of values for 12-14 mice. Note that the number of activated Ly5a 
CD21highCD23low and CD21lowCD23low present among the second set of B cells was not 
modified by the first set of B cells. d, IgMb levels produced by a second population of WT 
(left) or SHIP1-deficient (right) B cells transferred into Rag-deficient mice injected 4 weeks 
before with cells from WT IgHa donors expressed as a % of the control levels obtained after 
their transfer into naïve Rag-deficient hosts. Note that the IgMb production by SHIP1-deficient 
B cells was not inhibited in the presence of a first population of WT B cells. Each bar 
represents the mean ± SD of values for 12-14 mice. Data shown were pooled from two 
independent experiments. e, The left panel shows the IgM concentrations present in the serum 
of age-matched WT littermates and FcRγIIB-/- mice. Each bar represents the mean ± SD of 
values for 8 mice. IgM titers in the mutant mice were significantly higher (** p < 0.01). The 
right panel shows the IgM concentrations present in the serum of age-matched WT littermates 
and SHIP1-/- mice. Each bar represents the mean ± SD of values for 4 mice. IgM titers in the 
mutant mice were significantly higher (* p < 0.05). 
Fig. 5 – (A) « Quorum sensing »: The presence of soluble IgG and the ability of the B cells to 
detect its levels are crucial to the homeostasis of the immune system. “Quorum sensing”: The 
IgG secreted by activated B cells is detected (sensed) by the inhibitory FcγRIIB expressed by 
B cells that prevents further B cell activation. That is to say: overall B cell populations adapt 
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their behavior according to the sensing of the quantities of IgG produced. (B) Failure of 
“Quorum sensing” by defective sensor molecule: The inability to detect soluble IgG because 
of defects in the FcγRIIB expression (in FcγRIIB-/- mice) or signaling (in SHIP1-/- mice) leads 
to hyper IgM syndromes and autoimmune disease. (C) Failure of “Quorum sensing” by 
absence of the sensed molecule IgG also leads to hyper IgM syndromes and autoimmune 
pathology. 
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